OUR PRODUCTS

MOBILE APPS

GENERAL INFO

CYTK

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Cytokinetics (CYTK) Earnings Date & Reports

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CYTK is expected to report earnings to rise 32.14% to -148 cents per share on October 30

Cytokinetics CYTK Stock Earnings Reports

Q3'25

Est.

$-1.48

Q2'25

Beat

by $0.30

Q1'25

Beat

by $0.01

Q4'24

Missed

by $0.04

Q3'24

Missed

by $0.13

The last earnings report on August 07 showed earnings per share of -112 cents, beating the estimate of -141 cents. With 97.04K shares outstanding, the current market capitalization sits at 4.08B.

View a ticker or compare two or three

Compare

Search For Dips Search For Dips

Annualized Return+29%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

CYTK

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CYTK
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CYTK showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a company which engages in discovery and development of small molecule drug therapeutics

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

350 Oyster Point Boulevard

Phone

+1 650 624-3000

Employees

564

Web

https://www.cytokinetics.com